OncoQuest Pharmaceuticals Inc Capital Reinvestment Ratio
OncoQuest Pharmaceuticals Inc capital reinvestment ratio. OncoQuest Pharmaceuticals Inc (078590) has a Capital Reinvestment Ratio of 0.15x as of March 2025, meaning it reinvests 0% of its operating cash flow (₩431.70 Million) in capital expenditures (₩62.84 Million). Check OncoQuest Pharmaceuticals Inc (078590) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of OncoQuest Pharmaceuticals Inc (2014–2025)
Capital reinvestment ratio of OncoQuest Pharmaceuticals Inc from 2014 to 2025. This chart tracks OncoQuest Pharmaceuticals Inc's Capital Reinvestment Ratio across 9 annual periods. Also explore OncoQuest Pharmaceuticals Inc equity growth rate to track the company's year-over-year net asset growth rate.
OncoQuest Pharmaceuticals Inc Capital Reinvestment Ratio by Year (2014–2025)
OncoQuest Pharmaceuticals Inc capital reinvestment ratio by year from 2014 to 2025. For the full cash flow conversion analysis, see 078590 operating cash flow.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 2.43x | ₩485.35 Million | ₩1.18 Billion | ▲ +283.1% |
| 2024 | 0.63x | ₩3.96 Billion | ₩2.51 Billion | ▲ +274.4% |
| 2023 | 0.17x | ₩11.19 Billion | ₩1.90 Billion | ▼ -63.1% |
| 2020 | 0.46x | ₩7.55 Billion | ₩3.48 Billion | ▼ -50.1% |
| 2018 | 0.92x | ₩1.44 Billion | ₩1.33 Billion | ▲ +245.5% |
| 2017 | 0.27x | ₩4.79 Billion | ₩1.28 Billion | ▼ -41.2% |
| 2016 | 0.45x | ₩3.54 Billion | ₩1.61 Billion | ▼ -56.4% |
| 2015 | 1.04x | ₩2.79 Billion | ₩2.91 Billion | ▼ -10.4% |
| 2014 | 1.16x | ₩1.02 Billion | ₩1.18 Billion | — |